03 May 2023
19 April 2023
24 April 2023
18 April 2023
2021 Sales
...
05 June 2023
Areas of focus
...
-
18 November 2024
-
18 November 2024
Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS
PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-term efficacy and safety of patients treated with Bylvay® from two Phase III ope...
-
05 June 2023
-
05 June 2023
-
18 April 2023
-
18 April 2023
CSR Initiatives
...
-
13 April 2023
-
13 April 2023
Fondation Ipsen
Building on Fondation Ipsen’s legacy of engaging the public and the scientific community, our Rare But Not Alone strategy focuses on rare disease awareness and early detection. Our goal is ambitious but must be achieved to end the unnecessary suffering c...
-
05 June 2023
-
05 June 2023
Grant Requests
...